Lilly's Omvoh® (Mirikizumab) Recommended by Chmp for Approval in the European Union for Adults With Moderately to Severely Active Crohn's Disease
Lilly的Omvoh®(Mirikizumab)被CHMP推薦在歐盟批准用於中度至重度活動性的克羅恩病成人患者。
Lilly's Omvoh® (Mirikizumab) Recommended by Chmp for Approval in the European Union for Adults With Moderately to Severely Active Crohn's Disease
Lilly的Omvoh®(Mirikizumab)被CHMP推薦在歐盟批准用於中度至重度活動性的克羅恩病成人患者。
使用瀏覽器的分享功能,分享給你的好友吧